Who is sponsoring NCT06807021?

NCT06807021 is sponsored by Birch BioMed Inc.

What condition does NCT06807021 study?

NCT06807021 studies Burn Scar, Burn Wound.

What drugs are being tested in NCT06807021?

Interventions: IP1 control cream (Vehicle base), IP2 - 0.5% w/w FS2.

What is the status of NCT06807021?

NCT06807021 is currently RECRUITING.

Last reviewed 2025-11-17 · How we verify

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

NCT06807021 PHASE2, PHASE3 RECRUITING

The goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the skin was taken (donor site). The cream will be applied after the skin has healed. This study will help us understand if FS2 is safe and effective for mitigating skin scar formation in burn patients.

Details

Lead sponsor	Birch BioMed Inc
Phase	PHASE2, PHASE3
Status	RECRUITING
Enrolment	70
Start date	Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Nov 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Burn Scar
Burn Wound

Interventions

IP1 control cream (Vehicle base)
IP2 - 0.5% w/w FS2

Countries

Canada